This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

One-Year Relapse Rates

Gerard E. Hogarty, MSW; Solomon C. Goldberg Rockville, Md

Arch Gen Psychiatry. 1973;28(1):54-64.

Abstract
The posthospital treatment of 374 schizophrenics was controlled and evaluated for two years. Relapse rates for the first year were recorded.

At clinic intake, patients were randomly assigned to major role therapy (MRT; social casework and vocational rehabilitation counseling) and stabilized through the administration of chlorpromazine. After two months, further assignment to drug or placebo was made. Four groups were studied in each of three aftercare clinics: placebo alone; placebo and MRT; drug alone; drug and MRT.

Relapse in the placebo group is twice that of the drug group, but one half of all relapsers (drug and placebo) cease medication prior to relapse. The prophylactic action of the drug is established for many remitted schizophrenics. The MRT also lowers relapse rate significantly, but only after six months. Drug and sociotherapy effects are additive rather interactive by 12 months. Results replicate across all clinics.

Author Affiliations
Baltimore; the Collaborative Study Group, Baltimore

From Social Science Research, Friends Medical Science Research Center, Inc. (Mr. Hogarty and the Collaborative Study Group) and the Psychopharmacology Research Branch, National Institute of Mental Health, Rockville, Md (Dr. Goldberg).

Footnotes
Received for publication March 30, 1972; accepted May 15.

Reprint requests to 102 Bloomsbury Ave, Baltimore 21228 (Mr. Hogarty).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Gerard E. Hogarty (1935 2006): Combining Science and Humanism to Improve the Care of Persons With Schizophrenia
Eack et al.
Schizophr Bull 2007;33:1056-1062.
ABSTRACT | FULL TEXT  

Something out of nothing: the placebo effect
Vallance
Adv. Psychiatr. Treat. 2006;12:287-296.
ABSTRACT | FULL TEXT  

Cognitive Enhancement Therapy for Schizophrenia: Effects of a 2-Year Randomized Trial on Cognition and Behavior
Hogarty et al.
Arch Gen Psychiatry 2004;61:866-876.
ABSTRACT | FULL TEXT  

Controversies in Psychiatric Services in Hong Kong: Social Workers' Superiority and Inferiority Complexes
Yip
International Social Work 2004;47:240-258.
ABSTRACT  

Response to Vocational Rehabilitation During Treatment With First- or Second-Generation Antipsychotics
Bond et al.
Psychiatr. Serv. 2004;55:59-66.
ABSTRACT | FULL TEXT  

Three-Year Trials of Personal Therapy Among Schizophrenic Patients Living With or Independent of Family, I: Description of Study and Effects on Relapse Rates
Hogarty et al.
Focus 2004;2:146-157.
ABSTRACT | FULL TEXT  

The Role of Adherence on the Effectiveness of Nonpharmacologic Interventions: Evidence From the Delirium Prevention Trial
Inouye et al.
Arch Intern Med 2003;163:958-964.
ABSTRACT | FULL TEXT  

User's Guide to the Orthopaedic Literature: How to Use an Article About a Surgical Therapy
Bhandari et al.
JBJS 2001;83:916-926.
ABSTRACT | FULL TEXT  

Compliance With Medication Regimens for Mental and Physical Disorders
Cramer and Rosenheck
Psychiatr. Serv. 1998;49:196-201.
ABSTRACT | FULL TEXT  

Three-Year Trials of Personal Therapy Among Schizophrenic Patients Living With or Independent of Family, I: Description of Study and Effects on Relapse Rates
Hogarty et al.
Am. J. Psychiatry 1997;154:1504-1513.
ABSTRACT | FULL TEXT  

Neuroleptic Withdrawal in Schizophrenic Patients: A Review of the Literature
Gilbert et al.
Arch Gen Psychiatry 1995;52:173-188.
ABSTRACT  

Users' Guides to the Medical Literature: II. How to Use an Article About Therapy or Prevention A. Are the Results of the Study Valid?
Guyatt et al.
JAMA 1993;270:2598-2601.
ABSTRACT  

Adherence to Treatment and Health Outcomes
Horwitz and Horwitz
Arch Intern Med 1993;153:1863-1868.
ABSTRACT  

Adherence to Medication Regimens: Updating a Complex Medical Issue
O'Brien et al.
Med Care Res Rev 1992;49:435-454.
 

Intermittent vs Maintenance Medication in Schizophrenia: Two-Year Results
Herz et al.
Arch Gen Psychiatry 1991;48:333-339.
ABSTRACT  

American College of Chest Physicians and the National Heart, Lung, and Blood Institute National Conference on Antithrombotic Therapy
Dalen et al.
Arch Intern Med 1986;146:462-472.
ABSTRACT  

The Economic Costs of Schizophrenia: Implications for Public Policy
Andrews et al.
Arch Gen Psychiatry 1985;42:537-543.
ABSTRACT  

Anticholinergic Challenge and Neuroleptic Withdrawal: Changes in Dyskinesia and Symptom Measures
Gardos et al.
Arch Gen Psychiatry 1984;41:1030-1035.
ABSTRACT  

A Miniature Compliance Monitor for Eyedrop Medication
Kass et al.
Arch Ophthalmol 1984;102:1550-1554.
ABSTRACT  

The Chestnut Lodge Follow-up Study: I. Follow-up Methodology and Study Sample
McGlashan
Arch Gen Psychiatry 1984;41:573-585.
ABSTRACT  

Low-Dose Neuroleptic Treatment of Outpatient Schizophrenics: I. Preliminary Results for Relapse Rates
Kane et al.
Arch Gen Psychiatry 1983;40:893-896.
ABSTRACT  

Integrating Psychopharmacology and Contemporary Psychoanalytic Group Psychotherapy
Astigueta
Small Group Research 1983;14:261-268.
 

The Evaluation of Group Therapy in the Treatment of Schizophrenia
Scott and Griffith
Small Group Research 1982;13:415-422.
 

Adherence to Treatment Regimen in a Lithium Carbonate Clinic
Connelly et al.
Arch Gen Psychiatry 1982;39:585-588.
ABSTRACT  

Fluphenazine vs Placebo in Patients With Remitted, Acute First-Episode Schizophrenia
Kane et al.
Arch Gen Psychiatry 1982;39:70-73.
ABSTRACT  

Fluphenazine and Social Therapy in the Aftercare of Schizophrenic Patients: Relapse Analyses of a Two-Year Controlled Study of Fluphenazine Decanoate and Fluphenazine Hydrochloride
Hogarty et al.
Arch Gen Psychiatry 1979;36:1283-1294.
ABSTRACT  

Day Treatment and Psychotropic Drugs in the Aftercare of Schizophrenic Patients: A Veterans Administration Cooperative Study
Linn et al.
Arch Gen Psychiatry 1979;36:1055-1066.
ABSTRACT  

Drug and Family Therapy in the Aftercare of Acute Schizophrenics
Goldstein et al.
Arch Gen Psychiatry 1978;35:1169-1177.
ABSTRACT  

Who Cares?
Ingram
The Journal of the Royal Society for the Promotion of Health 1978;98:108-112.
 

Ward Treatment Milieu and Posthospital Functioning
Klass et al.
Arch Gen Psychiatry 1977;34:1047-1052.
ABSTRACT  

Temporal Effects of Drug and Placebo in Delaying Relapse in Schizophrenic Outpatients
Hogarty and Ulrich
Arch Gen Psychiatry 1977;34:297-301.
ABSTRACT  

Drug Refusal in Schizophrenia and the Wish to Be Crazy
Van Putten et al.
Arch Gen Psychiatry 1976;33:1443-1446.
ABSTRACT  

Concordance of Multiple Assessments of the Outcome of Schizophrenia: On Defining the Dependent Variable in Outcome Studies
Schwartz et al.
Arch Gen Psychiatry 1975;32:1221-1227.
ABSTRACT  

Amitriptyline-Perphenazine Interaction in Ambulatory Schizophrenic Patients: A Controlled Study of Drug Interaction
Chouinard et al.
Arch Gen Psychiatry 1975;32:1295-1307.
ABSTRACT  

Comparative Studies of Psychotherapies: Is It True That "Everyone Has Won and All Must Have Prizes"?
Luborsky et al.
Arch Gen Psychiatry 1975;32:995-1008.
ABSTRACT  

Social consequences of policy toward mental illness
Arnhoff
Science 1975;188:1277-1281.
 

Drug and Sociotherapy in the Aftercare of Schizophrenic Patients: II. Two-Year Relapse Rates
Hogarty et al.
Arch Gen Psychiatry 1974;31:603-608.
ABSTRACT  

Drug and Sociotherapy in the Aftercare of Schizophrenic Patients: III. Adjustment of Nonrelapsed Patients
Hogarty et al.
Arch Gen Psychiatry 1974;31:609-618.
ABSTRACT  

Group Therapy and Maintenance Treatment of Schizophrenics
Claghorn et al.
Arch Gen Psychiatry 1974;31:361-365.
ABSTRACT  

Symptomatic Outcome in Schizophrenia
Astrachan et al.
Arch Gen Psychiatry 1974;31:155-160.
ABSTRACT  

Clinical Psychopharmacology in Its 20th Year
Crane
Science 1973;181:124-128.
 

Neurological Syndromes Associated With Antipsychotic Drug Use: A Special Report
FREEDMAN
Arch Gen Psychiatry 1973;28:463-467.
ABSTRACT